Validation of POD24 As a Robust Early Clinical Indicator of Poor Survival in Mantle Cell Lymphoma from 1280 Patients on Clinical Trials, a LYSA Study
Clémentine Sarkozy,Loïc Chartier,Vincent Ribrag,Remy Gressin,Christian H Geisler, Hanneke C Kluin-Nelemans,Catherine Thieblemont,Franck Morschhauser,François Lemonnier,Violaine Safar,Benoît Tessoulin,Lucie Oberic,Ghandi Damaj,Hervé Ghesquières,Krimo Bouabdallah,René Olivier Casasnovas,Roch Houot,Wolfram Klapper,Barbara Burroni,Christiane Pott, Marie-Hélène Delfau-Larue,Elizabeth Macintyre,Mary Callanan,Mats Jerkeman,Michael Unterhalt,Eva Hoster,Martin Dreyling,Steven Le Gouill,Olivier Hermine,Morgane Cheminant Blood cancer journal（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper